Cargando…

Refinement of prognosis and the effect of azacitidine in intermediate-risk myelodysplastic syndromes

Detalles Bibliográficos
Autores principales:	Liapis, Konstantinos, Papadopoulos, Vasileios, Vrachiolias, George, Galanopoulos, Athanasios G., Papoutselis, Menelaos, Papageorgiou, Sotirios G., Diamantopoulos, Panagiotis T., Pappa, Vassiliki, Viniou, Nora-Athina, Kourakli, Alexandra, Τsokanas, Dimitris, Vassilakopoulos, Theodoros P., Hatzimichael, Eleftheria, Bouronikou, Eleni, Ximeri, Maria, Pontikoglou, Charalambos, Megalakaki, Aekaterini, Zikos, Panagiotis, Panayiotidis, Panayiotis, Dimou, Maria, Karakatsanis, Stamatis, Papaioannou, Maria, Vardi, Anna, Kontopidou, Flora, Harchalakis, Nikolaos, Adamopoulos, Ioannis, Symeonidis, Argiris, Kotsianidis, Ioannis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878783/ https://www.ncbi.nlm.nih.gov/pubmed/33574231 http://dx.doi.org/10.1038/s41408-021-00424-4

Ejemplares similares

Risk factors for cardiovascular disease mortality in patients with myelodysplastic syndromes: A nationwide, registry‐based cohort study
por: Liapis, Konstantinos, et al.
Publicado: (2020)

The prognostic significance of chromosome 17 abnormalities in patients with myelodysplastic syndrome treated with 5‐azacytidine: Results from the Hellenic 5‐azacytidine registry
por: Diamantopoulos, Panagiotis, et al.
Publicado: (2019)

Serum ferritin and ECOG performance status predict the response and improve the prognostic value of IPSS or IPSS-R in patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia treated with 5-azacytidine: a retrospective analysis of the Hellenic national registry of myelodysplastic and hypoplastic syndromes
por: Papageorgiou, Sotirios G., et al.
Publicado: (2020)

Azacytidine Failure Revisited: an Appraisal Based on Real-Life Data from the MDS Registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS)
por: Kotsianidis, Ioannis, et al.
Publicado: (2019)

Common cardiovascular biomarkers can independently predict outcome of patients with Myelodysplastic syndromes
por: Mitroulis, Ioannis, et al.
Publicado: (2023)

Real world data on the prognostic significance of monocytopenia in myelodysplastic syndrome
por: Diamantopoulos, Panagiotis T., et al.
Publicado: (2022)

Blood and platelet transfusion from a donor with presymptomatic Covid-19
por: Liapis, Konstantinos, et al.
Publicado: (2020)

P706: RESISTANCE TO HYPOMETHYLATING AGENTS (HMA) IN HIGH-RISKMYELODYSPLASTIC SYNDROME (HR-MDS): THE ROLE OF THE ADENOSINEDEAMINASE ACTING ON RNA 1 (ADAR1) ENZYME
por: Dimitriou, Despoina, et al.
Publicado: (2023)

Evaluation of complete response to azacitidine according to the revised International Working Group 2023 response criteria for higher risk MDS. Does it make a difference in patients’ outcome?
por: Bouchla, Anthi, et al.
Publicado: (2023)

P1606: PRIMARY AND SECONDARY IMMUNE THROMBOCYTOPENIA (ITP) IN ADULTS: REAL WORLD COMPARATIVE RETROSPECTIVE STUDY FROM THE ITP REGISTRY OF THE HELLENIC SOCIETY OF HEMATOLOGY
por: Stavroulaki, Emily, et al.
Publicado: (2023)

A personalized stepwise dynamic predictive algorithm of the time to first treatment in chronic lymphocytic leukemia
por: Moysiadis, Theodoros, et al.
Publicado: (2023)

P1646: PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) IN PATIENTS OLDER THAN 75 YEARS: REAL WORLD DATA FROM THE ITP REGISTRY OF THE HELLENIC SOCIETY OF HEMATOLOGY
por: Pontikoglou, C., et al.
Publicado: (2022)

Approaching First-Line Treatment in Patients With Advanced CMML: Hypomethylating Agents or Cytotoxic Treatment?
por: Liapis, Konstantinos, et al.
Publicado: (2021)

Epigenetic therapy of myelodysplastic syndromes connects to cellular differentiation independently of endogenous retroelement derepression
por: Kazachenka, Anastasiya, et al.
Publicado: (2019)

Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival
por: Katodritou, Eirini, et al.
Publicado: (2018)

The incidence of myelodysplastic syndromes in Western Greece is increasing
por: Avgerinou, Christina, et al.
Publicado: (2013)

Allogeneic Hematopoietic Stem Cell Transplantation for Mixed or Overlap Myelodysplastic/Myeloproliferative Disorders
por: Symeonidis, Argiris, et al.
Publicado: (2022)

Distal Clavicle Osteochondroma Causing Supraspinatus Tendinopathy
por: Galanopoulos, Ioannis, et al.
Publicado: (2019)

The JAK2V617F Point Mutation Increases the Osteoclast Forming Ability of Monocytes in Patients with Chronic Myeloproliferative Neoplasms and Makes their Osteoclasts more Susceptible to JAK2 Inhibition
por: Spanoudakis, Emmanouil, et al.
Publicado: (2018)

P701: SYSTEMATIC ANALYSIS OF T LYMPHOCYTES IN MYELOID NEOPLASMS
por: Tasis, Athanasios, et al.
Publicado: (2023)

Off-Label Use of Teriparatide in Spine
por: Drakopoulos, Panagiotis, et al.
Publicado: (2021)

Autophagy Mediates the Delivery of Thrombogenic Tissue Factor to Neutrophil Extracellular Traps in Human Sepsis
por: Kambas, Konstantinos, et al.
Publicado: (2012)

Tyrosine Kinase Inhibitors and Interferon
por: Dimou, Maria, et al.
Publicado: (2014)

Myeloid Neoplasms with Isolated Isochromosome 17q: a yet to be Defined Entity
por: Lamprianidou, Eleftheria, et al.
Publicado: (2017)

Ankle Fractures in Diabetic Patients: Report of Two Cases
por: Galanopoulos, Ioannis P, et al.
Publicado: (2021)

TACI Mutations in Primary Antibody Deficiencies: A Nationwide Study in Greece
por: Kakkas, Ioannis, et al.
Publicado: (2021)

Diagnosis and treatment complications of primary cardiac lymphoma in an immunocompetent 28-year old man: a case report
por: Bonou, Maria, et al.
Publicado: (2019)

Primary Hepatic Burkitt Lymphoma in a Kidney Transplant Recipient
por: Lionaki, Sophia, et al.
Publicado: (2018)

A case report of Hodgkin lymphoma in a patient treated with ustekinumab for psoriasis
por: Charakopoulos, Emmanouil, et al.
Publicado: (2020)

Anomalous course of the sigmoid colon and the mesosigmoid encountered during colectomy. A case report of a redundant loop of sigmoid colon
por: Zarokosta, Maria, et al.
Publicado: (2018)

A Primary Hepatic Lymphoma Treated with Liver Resection and Chemotherapy
por: Bouliaris, Konstantinos, et al.
Publicado: (2014)

Prognostic significance of signal transducer and activator of transcription 5 and 5b expression in Epstein–Barr virus‐positive patients with chronic lymphocytic leukemia
por: Diamantopoulos, Panagiotis T., et al.
Publicado: (2016)

The Clinical and Prognostic Significance of Ribonucleotide Reductase Subunits RRM1 and RRM2 mRNA Levels in Patients with Chronic Lymphocytic Leukemia
por: Chatzidavid, Sevastianos, et al.
Publicado: (2023)

Rapidly Progressive Pauci-Immune Glomerulonephritis with Aberrant Fibrinoid Necrosis Associated with Atezolizumab, an Immune Check Point Inhibitor: A Case Report and Review of Literature
por: Nikolopoulos, Petros, et al.
Publicado: (2023)

Atypical Chronic Myelogenous Leukemia, BCR-ABL1 Negative: Diagnostic Criteria and Treatment Approaches
por: Diamantopoulos, Panagiotis T., et al.
Publicado: (2021)

An unusual case report of unilateral parotid gland sarcoidosis with spontaneous remission
por: Diamantopoulos, Panagiotis T., et al.
Publicado: (2019)

Immunoporosis: A New Role for Invariant Natural Killer T (NKT) Cells Through Overexpression of Nuclear Factor-κB Ligand (RANKL)
por: Tilkeridis, Konstantinos, et al.
Publicado: (2019)

Immunogenicity of a third dose of the BNT162b2 COVID-19 vaccine in patients with CLL: effects on treatment selection
por: Diamantopoulos, Panagiotis T., et al.
Publicado: (2022)

miRNA-seq identification and clinical validation of CD138+ and circulating miR-25 in treatment response of multiple myeloma
por: Papadimitriou, Maria-Alexandra, et al.
Publicado: (2023)

Chronic Neutrophilic Leukemia: A Comprehensive Review of Clinical Characteristics, Genetic Landscape and Management
por: Thomopoulos, Thomas P., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_780n6vbljjjafvrqg39vhrhrit